Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 13, 2023Blood ReviewsOpen Access

Do anemia treatments improve quality of life and physical function in patients with myelodysplastic syndromes (MDS)? A systematic review

View Full Paper
Ask AI
Bookmark
Share

Authors

AMAllison MoMPMatt PoyntonEWErica M. Wood

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Mo et al. (2023) studied this question.

synapsesocial.com/papers/6ab46efa300aaa803d56962chttps://doi.org/10.1016/j.blre.2023.101114
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Cognitive impairment, fatigue, and cytokine levels in patients with acute myelogenous leukemia or myelodysplastic syndrome2005 · 460 citations
  2. 2Quality of life and use of red cell transfusion in patients with myelodysplastic syndromes. A systematic review2009 · 59 citations
  3. 3Missing quality of life data in cancer clinical trials: serious problems and challenges1998 · 211 citations
  4. 4ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions2016 · 20,265 citations
  5. 5A phase 3 randomized, placebo-controlled study assessing the efficacy and safety of epoetin-α in anemic patients with low-risk MDS2018 · 164 citations